Changeflow GovPing Pharma & Drug Safety New Drug Approvals February 2026
Routine Notice Added Final

New Drug Approvals February 2026

Favicon for www.hsa.gov.sg HSA Singapore Announcements
Published
Detected
Email

Summary

The Health Sciences Authority (HSA) Singapore announced new therapeutic product approvals granted in February 2026. The announcement lists newly approved therapeutic products and new indications approved for registered therapeutic products. Healthcare professionals and industry members are directed to the listing for details.

Published by HSA on hsa.gov.sg . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

HSA Singapore published a routine announcement listing new therapeutic product approvals granted in February 2026. The listing includes newly approved therapeutic products and new indications for previously registered products.

Healthcare professionals and pharmaceutical companies should review the approved products listing to identify relevant approvals and ensure their product portfolios remain current with regulatory decisions. This is an informational notice with no immediate compliance obligations beyond awareness.

What to do next

  1. Review approved therapeutic products listing for relevant products

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

New approvals - Feb 2026

Please click here to view the lists of the latest therapeutic product approvals and new indications approved for registered therapeutic products. Healthcare professional, Industry member, Therapeutic Products Published:

14 Apr 2026

Subscribe to stay up to date with HSA news and regulatory updates.

New Drug Approvals

14 Apr 2026

Get daily alerts for HSA Singapore Announcements

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from HSA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
HSA
Published
April 14th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug approvals Therapeutic product registration
Geographic scope
Singapore SG

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare

Get alerts for this source

We'll email you when HSA Singapore Announcements publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!